| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |